Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States

BACKGROUND: As real-world data resources expand and improve, there will increasingly be opportunities to study the effectiveness of interventions. There is a need to ensure that study designs explore potential sources of bias and either acknowledge or mitigate them, in order to improve the accuracy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, Lisa M, Grabner, Michael, Wang, Liya, Liepa, Astra M, Li, Xiaohong Ivy, Cui, Zhanglin Lin, Bowman, Lee, Schelman, William R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205419/
https://www.ncbi.nlm.nih.gov/pubmed/32431558
http://dx.doi.org/10.2147/POR.S241427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205419/
https://www.ncbi.nlm.nih.gov/pubmed/32431558
http://dx.doi.org/10.2147/POR.S241427

Ejemplares similares